CHEMED CORP

Chemed Corporation reported strong financial results for the second quarter of 2026, with consolidated revenue increasing by 8.8% and GAAP diluted EPS rising by 43.7%. The VITAS segment showed significant outperformance, leading to an upward revision of the company's full-year guidance for adjusted diluted EPS. The Roto-Rooter segment also contributed positively with a 3.3% revenue increase.

Chemed Corporation reported strong financial results for Q2 2026, with consolidated revenue increasing 8.8% to $673.3 million and adjusted diluted EPS rising 41.9% to $6.06. The VITAS segment showed significant growth, driven by increased patient revenue and admissions, while the Roto-Rooter segment experienced modest revenue growth. The company also raised its full-year 2026 adjusted diluted EPS guidance to $25.00-$25.75 and repurchased $89.8 million in shares during the quarter.

Chemed Corporation's wholly-owned subsidiary, Roto-Rooter Services Company, has acquired a formerly independent Roto-Rooter franchise in south Texas for approximately $12.0 million. This acquisition expands Roto-Rooter's service area to 21 counties, encompassing major cities such as Corpus Christi, McAllen, Laredo, and Brownsville. Chemed Corporation, listed on the NYSE, operates VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, a leading provider of plumbing and drain cleaning services.

Chemed Corporation stockholders elected nine directors and ratified PricewaterhouseCoopers LLP as independent accountants for 2026 at the annual meeting. Notably, a non-binding proposal on executive compensation was not approved. Following the meeting, Chemed's Board of Directors declared a quarterly cash dividend of $0.60 per share, marking the company's 220th consecutive quarterly dividend.

Chemed Corporation announced it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on May 20, 2026, at approximately 8:30 a.m. ET. The presentation will be held at The InterContinental New York Barclay Hotel in New York City. Investors can access an audio webcast of the presentation on the company's website, with a replay available for 90 days. Chemed operates VITAS Healthcare, the nation's largest provider of end-of-life hospice care, and Roto-Rooter, a leading provider of plumbing and drain cleaning services.

CHEMED CORP reported Q1 2026 service revenues and sales of $657.5 million, a 1.6% increase year-over-year, while net income decreased by 7.6% to $66.3 million. Diluted EPS was $4.84, down from $4.86 in Q1 2025. The company increased its cash dividend per share to $0.60 and significantly increased share repurchases to $190.0 million. Additionally, CHEMED replaced its credit facility with a new $450.0 million revolving credit facility in April 2026.

Chemed Corporation reported Q1 2026 financial results, with consolidated revenue increasing 1.6% to $657.5 million and adjusted diluted EPS rising 0.4% to $5.65. The company increased its full-year guidance, citing strong VITAS performance. During the quarter, Chemed repurchased 500,000 shares and acquired two Roto-Rooter franchises for $20.6 million.

Chemed Corporation renewed its $450 million senior secured credit facilities on April 10, 2026. The new facilities consist of a five-year revolving credit facility, including $100 million for letters of credit. The interest rate is a floating rate based on SOFR plus a tiered rate tied to the company's leverage ratio, and it includes an expansion feature allowing for an additional $250 million increase. This renewal ensures continued financial flexibility for the company.

Chemed Corporation announced it has entered into an Amended and Restated Credit Agreement for a new five-year $450 million revolving credit facility. This facility includes $100 million for letters of credit and an expansion feature that provides the opportunity to increase the revolver by an additional $250 million. The interest rate is a floating rate generally based on SOFR plus an additional tiered rate. This agreement enhances Chemed's financial flexibility for its operations, which include VITAS Healthcare and Roto-Rooter.